Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
企業コードAIFF
会社名Firefly Neuroscience Inc
上場日Oct 27, 1993
最高経営責任者「CEO」Mr. Greg Lipschitz
従業員数13
証券種類Ordinary Share
決算期末Oct 27
本社所在地1100 Military Road
都市KENMORE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号14217
電話番号18882376412
ウェブサイトhttps://fireflyneuro.com/
企業コードAIFF
上場日Oct 27, 1993
最高経営責任者「CEO」Mr. Greg Lipschitz
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし